Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Rojas (Pittsburgh, United States of America). Mesenchymal stem cells in aging and IPF. ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research

Member's Comments

No comment yet.

Related content which might interest you: Mesenchymal stem cells and fibrotic lung diseases Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 Mesenchymal stem cell therapy for severe emphysema Source: Virtual Congress 2021 – Repair and regeneration in chronic lung disease and lung cancer Year: 2021 Mesenchymal stem cell therapy for severe emphysema Source: ERS Lung Science Conference 2021 Year: 2021 Mesenchymal stem cells and their potential for clinical use Source: Annual Congress 2004 - Cellular and molecular strategies to repair the damaged lung Year: 2004 Mesenchymal cells, immune cells and the lung stem cell niche Source: Eur Respir Monogr 2021; 91: 134-143 Year: 2021 Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 Mesenchymal lineage formation in the lung during development and disease Source: International Congress 2017 – Molecular pathways in lung development Year: 2017 YI05 - Mesenchymal stromal cells identified in tissue from lung-transplanted patients Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration Year: 2012 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021 Derivation of epithelial-only airway organoids from human pluripotent stem cells Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 Modelling human lung development and disease using pluripotent stem cells Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats Year: 2015 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: ERS Lung Science Conference 2021 Year: 2021 Metabolic reprogramming by mesenchymal stem cells as a strategy for lung repair Source: ERS Lung Science Conference 2020 Year: 2020 Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021